These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical evaluation of ceftazidime in internal medicine in Japan. Shimada K. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():395-7. PubMed ID: 6225765 [Abstract] [Full Text] [Related]
26. Ceftazidime treatment in intensive care patients. van Dalen R, Muytjens HL, Gimbrère JS. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():189-97. PubMed ID: 6225763 [Abstract] [Full Text] [Related]
27. Ceftazidime in the treatment of complicated respiratory and urinary tract infections. Loebis LH, Williams KJ. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():59-64. PubMed ID: 6352656 [Abstract] [Full Text] [Related]
28. Ceftazidime, as a single antibiotic, in the treatment of multi-resistant Gram-negative infections in intensive care. Gasparetto A, Delogu G. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():171-5. PubMed ID: 6352617 [Abstract] [Full Text] [Related]
30. The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients. Walstad RA, Hellum KB, Svarva PL, Ingram PM. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():131-7. PubMed ID: 6352614 [Abstract] [Full Text] [Related]
31. [Usefulness of ceftazidime in intractable respiratory tract infections]. Takenaka S, Fukuda K, Kimura T, Shima K, Ushijima M, Egashira Y, Ikeda S, Hiraoka T, Higuchi S, Fujise T. Jpn J Antibiot; 1989 Dec; 42(12):2555-65. PubMed ID: 2693754 [Abstract] [Full Text] [Related]
32. Ceftazidime: a new approach in the treatment of moderate and severe infections. Abbas AM, Taylor MC, Newby D, Jones RB, Rigby CC, Haste AR, Cantor AM. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():147-52. PubMed ID: 6352615 [Abstract] [Full Text] [Related]
33. Ceftazidime in patients with Pseudomonas infections. Eron LJ, Park CH, Hixon DL, Goldenberg RI, Poretz DM. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():161-9. PubMed ID: 6225762 [Abstract] [Full Text] [Related]
35. An open study of ceftazidime in the treatment of serious bacterial infection. Allan SG, Glover SC, Smith CC, Hadley KM, Reid TM, Han K, Murdoch JM, Ingram PM. J Antimicrob Chemother; 1983 Sep; 12(3):219-27. PubMed ID: 6355044 [Abstract] [Full Text] [Related]
36. Ceftazidime: therapeutic results in various infections. Sakellariou G, Alexopoulos E, Natshe T, Hadjidimitriou C, Kalpakoglou S, Karayiannis A, Papadimitriou M. Chemioterapia; 1987 Jun; 6(2 Suppl):373-4. PubMed ID: 3334579 [No Abstract] [Full Text] [Related]
37. [The use of ceftazidime in infectious pathology]. La Rosa F. Minerva Med; 1985 Sep 29; 76(37):1657-62. PubMed ID: 3900812 [Abstract] [Full Text] [Related]
38. Clinical evaluation of ceftazidime in Japan. Ishibiki K. J Antimicrob Chemother; 1983 Jul 29; 12 Suppl A():123-30. PubMed ID: 6225760 [Abstract] [Full Text] [Related]
39. Efficacy and tolerance of ceftazidime in the treatment of post-operative respiratory tract infections. Tinozzi S, Ferrari R, Belisomo M, Bianchi C, Sesana L, Massi Benedetti P, Benedetti M. Int J Clin Pharmacol Ther Toxicol; 1987 Sep 29; 25(9):519-21. PubMed ID: 3316060 [Abstract] [Full Text] [Related]
40. [Use of a new beta-lactam antibiotic, ceftazidime, in the neurosurgical intensive care unit. Preliminary observations]. Ravelli V, Buonaguidi R, Lutzemberger L. Minerva Anestesiol; 1985 Sep 29; 51(9):471-3. PubMed ID: 3913880 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]